Biofisica is an early stage medical device company developing products for the soft-tissue regeneration market. Currently the company is developing products for the wound care market using novel technologies.
Chromatin’s patented mini-chromosome technologies enable the development of new seed products and the delivery of multiple genetic traits. Consumers, growers, seed companies, and processors will derive greater value from crop plants through the application of Chromatin’s technologies. More efficient and faster product development, greater product differentiation, and creation of novel products are among the benefits Chromatin’s technologies deliver to these users.
Efficas is biotech development company committed to providing science-based products for nutritional management of the immune system. Efficas develops bioactive products that help manage specific health conditions related to the immune system. Through an in-depth understanding of immune system function, Efficas is uniquely positioned to provide safe, effective nutritional products to manage and improve immune system health for people and animals.
HaloSource® health science technologies focus on antimicrobial enhancing solutions that reliably and effectively kill germs. For partners that want competitive differentiation through unique proprietary technologies, HaloSource provides reliable, tested and proven solutions in the product categories of safe water, infection control and wound healing.
Impinj, Inc. is a fabless semiconductor company whose patented Self-Adaptive Silicon® technology enables its two synergistic business lines: high performance RFID products and innovative semiconductor intellectual property. As a leading contributor to the RFID standards for high-volume supply-chain applications worldwide, Impinj leverages its technical expertise and industry partnerships to deliver the GrandPrix™ solution of tag, reader, software and system integration to offer RFID that just works™. Impinj's innovative intellectual property products, core to the company's RFID tags, are licensed to leading semiconductor companies worldwide, allowing them to integrate crucial nonvolatile memory (NVM) alongside analog and digital functionality on a single chip. Impinj's IP products include the popular AEON® family of rewriteable NVM products.
Merged in 2008 with Rayne Corporation, Pionetics’ LINX technology represents a new generation of water purification for a world in which pure water becomes scarcer every day. Without using harmful chemicals, LINX technology eliminates 90% of total dissolved solids from water, delivers nearly twenty times more instantaneous water than other systems, eliminates storage tanks, and reduces wastewater. It is the only water purification technology to feature Dial-A-Taste™, which allows users to selectively retain minerals in purified water to vary the taste according to their liking.
Surface Logix is a drug development company using its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders. By using its proprietary chemistry platform — the Pharmacomer™ Technology Platform –Surface Logix creates New Chemical Entities that respond dynamically to the various physiological microenvironments in the human body. By enhancing molecular functionality, Surface Logix is able to solve PK and PD problems not addressable with traditional medicinal chemistry practices.
Purchased in 2008 by Adidas Group, Textronics™ is a pioneer in the field of textile electronics. The convergence of high-tech fiber science with electronics and optics is at an early stage. However it has the potential to revolutionize fabrics from clothing to industrial textiles and significantly impact other textile sectors in the next decade. Textronics has technology streams under development that will enable energy-active fabric systems to deliver new kinds of functional benefits. Possibilities include fabrics that warm, illuminate, conduct, sense, and respond to various stimuli. These benefits will be most immediately relevant to specialist applications in medicine, sports, communications, and personal security, among others, but will ultimately have broad consumer relevance.
